LncRNA HULC As a Potential Predictor of Prognosis and Clinicopathological Features in Patients with Digestive System Tumors: a Meta-analysis

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2022 Feb 19

PMID 35183058

Authors

Duo Li

Rui Wang

Na Wu

Yongqiang Yu

Affiliations

Soon will be listed here.

Abstract

Objective: This meta-analysis aimed to evaluate the correlation between lncRNA HULC, prognosis and clinicopathological characteristics in patients with digestive system tumors.

Methods: The relevant literatures were collected through PubMed, Web of Science and Embase up to February 2021. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to assess the prognostic value of HULC in patients with digestive system tumors. The clinicopathological characteristics of HULC in patients were estimated by odds ratios (ORs).

Results: A total of 14 studies involving 1312 patients were included. The up-regulated expression level of HULC was associated with poorer overall survival (OS) in patients with digestive system tumors (HR = 1.83, 95% CI: 1.05-3.19, = 0.033). Subgroup analysis showed that cancer type (pancreatic cancer or gastric cancer), residence region (China, Japan or Korea), and specimen (serum) significantly associated between HULC and OS. In addition, high HULC expression significantly increased the risk of high TNM stage (OR = 2.51, 95%CI: 1.36-4.62, < 0.05), poor differentiation (OR = 1.38, 95%CI: 1.02-1.87, < 0.05) and lymphatic node metastasis (LNM, OR = 4.93, 95% CI: 3.47-6.99, < 0.05).

Conclusions: High expression level of HULC is related to OS, TNM stage, differentiation and LNM. Therefore, HULC can be used as a new potential predictor for prognosis and clinicopathological features of patients with digestive system tumors.

Citing Articles

Preoperative D‑dimer level and prognosis in patients diagnosed with gastric cancer and undergoing gastric cancer radical surgery: A retrospective cohort study.

Zhao Y, Han J, Yang R, Wang S, Zhang K, Lu H Oncol Lett. 2024; 29(1):64.

PMID: 39619170 PMC: 11606006. DOI: 10.3892/ol.2024.14810.

Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.

Zabeti Touchaei A, Vahidi S, Samadani A Clin Exp Med. 2024; 24(1):29.

PMID: 38294554 PMC: 10830721. DOI: 10.1007/s10238-023-01260-5.

Non-coding RNAs and gastrointestinal cancers prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies.

Zha B, Luo Y, Kamili M, Zha X Front Oncol. 2023; 13:1193665.

PMID: 37546412 PMC: 10399243. DOI: 10.3389/fonc.2023.1193665.

Creation of a Prognostic Model Using Cuproptosis-Associated Long Noncoding RNAs in Hepatocellular Carcinoma.

Yang L, Jia X, Fu Y, Tian J, Liu Y, Lin J Int J Mol Sci. 2023; 24(12).

PMID: 37373132 PMC: 10298112. DOI: 10.3390/ijms24129987.

References

Mahjoubin-Tehran M, Rezaei S, Jesmani A, Birang N, Morshedi K, Khanbabaei H . New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs. Biomed Pharmacother. 2021; 140:111753. PMC: 8222190. DOI: 10.1016/j.biopha.2021.111753. View

Jin C, Shi W, Wang F, Shen X, Qi J, Cong H . Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer. Oncotarget. 2016; 7(32):51763-51772. PMC: 5239513. DOI: 10.18632/oncotarget.10107. View

Yang X, Huang C, Peng C, Hou J, Liu J . Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression. Gene. 2016; 592(1):172-178. DOI: 10.1016/j.gene.2016.08.002. View

Abdi E, Latifi-Navid S, Abdi F, Taherian-Esfahani Z . Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers. Expert Rev Mol Diagn. 2020; 20(11):1121-1138. DOI: 10.1080/14737159.2020.1842199. View

Wang Y, Huang Y, Xiang P, Tian W . LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis. Onco Targets Ther. 2017; 10:5355-5361. PMC: 5687481. DOI: 10.2147/OTT.S149889. View

Chen X, Lun L, Hou H, Tian R, Zhang H, Zhang Y . The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis. Cell Physiol Biochem. 2017; 41(4):1424-1434. DOI: 10.1159/000468005. View

Li Y, Liu Y, Chen X, Zhu Y, Zhang H, Li Y . Effect of long non-coding RNA highly up-regulated in liver cancer (HULC) on the prognosis of cancer: a meta-analysis. Oncotarget. 2017; 8(47):83246-83250. PMC: 5669964. DOI: 10.18632/oncotarget.18452. View

Sarvizadeh M, Hasanpour O, Ghale-Noie Z, Mollazadeh S, Rezaei M, Pourghadamyari H . Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities. Front Oncol. 2021; 11:650256. PMC: 8111078. DOI: 10.3389/fonc.2021.650256. View

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

10.

Wapinski O, Chang H . Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21(6):354-61. DOI: 10.1016/j.tcb.2011.04.001. View

11.

Liu Y, Feng J, Sun M, Yang G, Yuan H, Wang Y . Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Cancer Lett. 2019; 454:158-170. DOI: 10.1016/j.canlet.2019.04.008. View

12.

Zhang Z, Qian W, Wang S, Ji D, Wang Q, Li J . Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Cell Physiol Biochem. 2018; 49(5):1778-1791. DOI: 10.1159/000493623. View

13.

Fan Y, Wu M, Jiang Y, Ye M, Lu S, Wu L . Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis. Oncotarget. 2017; 8(13):21410-21417. PMC: 5400593. DOI: 10.18632/oncotarget.15247. View

14.

Naeli P, Pourhanifeh M, Karimzadeh M, Shabaninejad Z, Movahedpour A, Tarrahimofrad H . Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol. 2019; 145:102854. PMC: 6982584. DOI: 10.1016/j.critrevonc.2019.102854. View

15.

Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J . HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Cell Physiol Biochem. 2015; 37(2):687-96. DOI: 10.1159/000430387. View

16.

Lyabin D, Eliseeva I, Ovchinnikov L . YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA. 2013; 5(1):95-110. DOI: 10.1002/wrna.1200. View

17.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

18.

Ashrafizadeh M, Zarrabi A, Hashemipour M, Vosough M, Najafi M, Shahinozzaman M . Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers. Pharmacol Res. 2020; 160:105199. DOI: 10.1016/j.phrs.2020.105199. View

19.

Wang C, Li Y, Yan S, Wang H, Shao X, Xiao M . Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. Nat Commun. 2020; 11(1):3162. PMC: 7308313. DOI: 10.1038/s41467-020-16966-3. View

20.

Wei Y, Niu B . Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis. Dis Markers. 2015; 2015:164635. PMC: 4572489. DOI: 10.1155/2015/164635. View